2018 Malaysia HFMD Outbreak

From WikiMD's Food, Medicine & Wellness Encyclopedia

2018 Malaysia HFMD Outbreak

The 2018 Malaysia HFMD Outbreak refers to a significant increase in the number of cases of hand, foot, and mouth disease (HFMD) in Malaysia during the year 2018. This outbreak was primarily caused by the Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16), both of which are common causes of HFMD.

Background[edit | edit source]

Hand, foot, and mouth disease is a common viral illness that primarily affects infants and children. The disease is characterized by fever, sores in the mouth, and a rash with blisters on hands, feet, and buttocks. It is typically a mild illness, but severe cases can occur, especially in children under 5 years old.

Outbreak[edit | edit source]

The 2018 Malaysia HFMD Outbreak began in early 2018 and peaked in July of the same year. The outbreak was widespread, affecting all states in Malaysia, with the highest number of cases reported in Penang, Sarawak, and Selangor. The outbreak resulted in over 40,000 reported cases and several deaths.

Response[edit | edit source]

The Malaysia Ministry of Health responded to the outbreak by increasing public awareness about the disease, promoting good hygiene practices, and closing affected schools and childcare centers. Despite these efforts, the outbreak continued for several months, highlighting the need for improved prevention and control measures.

Aftermath[edit | edit source]

The 2018 Malaysia HFMD Outbreak had significant impacts on public health, education, and the economy in Malaysia. It highlighted the need for improved surveillance, early detection, and rapid response to HFMD outbreaks. Since the outbreak, efforts have been made to develop a vaccine against EV71, one of the main causes of severe HFMD.

See also[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD